PKX-39220-99264 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-11-18
Dose 1 — Pfizer-BioNTech
Co-administered: Tetanus
2022-12-09
Dose 2 — Pfizer-BioNTech
2022-12-11
Registered in v-safe
2022-12-11
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-12-12
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-12-18
Survey response — 7 day, dose 2, dependent
MedDRA: Cough, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11 · check-in answers available
2022-12-23
Health check-in — 14 day, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-30
Health check-in — 21 day, dose 2, dependent
Feeling: Good

Adult check-in
2023-01-06
Health check-in — 28 day, dose 2, dependent
Feeling: Good

Adult check-in
2023-01-22
Health check-in — 42 day, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-11-18	Pfizer-BioNTech	Tetanus
2	2022-12-09	Pfizer-BioNTech	No

Free text

Release 12

Systemic reaction (other): Cough, runny nose

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Cough	·	·	✓
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release